USPTO serial 98677143
CELLCAGE
Reviewed by CopyMark Law Group
Status 730Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- COOK, RYAN ARMON
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with CELLCAGE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $549*
Plus Government fees of $600
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Foster City, CA, US
Foster City, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Timothy Sitzmann
Timothy Sitzmann WINTHROP & WEINSTINE, P.A.225 South Sixth StreetCapella Tower Suite 3500Minneapolis, MN 55402Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | chemical preparations for use in isolating cells for research and scientific purposes; Reagents and assays for research purposes; Biological preparations for use in isolating cells for research and scientific purposes; kits comprising chemical reagents, DNA sequences, nucleic acids, enzymes, microfluidic bio and DNA chips, nucleotides, and flow cell cartridges containing one or more of nucleic acids, nucleotides, DNA sequences, RNA sequences, biological material, or substrates, all for research, scientific, and industrial purposes | ACTIVE | — |
| 009 | laboratory equipment, namely, devices for genetic analysis, DNA sequencing, and proteomic analysis and recorded computer software for use and management of such equipment; bio-chips for research or scientific purposes; Research laboratory analyzers for measuring, testing and analyzing biological samples, blood, and other bodily fluids and recorded computer software for use and management of such analyzers; recorded computer software for medical and scientific research, namely, for data management and analysis, data organization and storage, data sharing, and for analyzing biological samples, for operation of laboratory analyzers, and for genetic analysis, all in the fields of multiomics, cellular analysis, DNA sequencing, biomarkers, bioinformatics, proteomics, genomics, secretomics, transcriptomics, and RNA sequencing; cartridges, flowcells being flow cell cartridges, flow cell bio-chips, laboratory equipment, laboratory instruments, research laboratory analyzers, and recorded computer software for isolating cells, genetic analysis, cellular analysis, therapeutic purposes, and for medical and scientific research purposes; cartridges, flowcells being flow cell cartridges, flow cell bio-chips, DNA chips and related laboratory instruments for molecular and biological analysis, for scientific and medical research purposes, research laboratory analyzers, and associated recorded software for isolating cells, for genetic analysis, for cellular analysis, and for scientific and medical research purposes | ACTIVE | — |
| 042 | software as a service (SAAS) services featuring software for cellular analysis and genetic analysis in the fields of genomics, multiomics, biomarkers, DNA sequencing, RNA sequencing, bioinformatics, proteomics, secretomics, and transcriptomics; custom design and development of chemical reagents and biochemical assays; research and consulting services in the fields of cellular analysis, genetic analysis genomics, multiomics, biomarkers, DNA sequencing, bioinformatics, proteomics, genomics, secretomics, transcriptomics, and RNA sequencing; Medical and scientific research; software as a service (SAAS) services featuring software for genetic and cellular research analysis and cellular testing in the fields of scientific research, clinical research, scientific diagnostics, and medical diagnostics ; design, engineering, research, development and testing services in the fields of cellular analysis, genetic analysis, genomics, multiomics, biomarkers, DNA sequencing, and bioinformatics, proteomics, genomics, secretomics, transcriptomics, and RNA sequencing; software as a service (SAAS) services featuring software for analyzing biological samples and collecting, managing, sharing, and analyzing data and generating cellular images; software as a service (SAAS) services featuring software for management and operation of laboratory equipment and research laboratory analyzers | ACTIVE | — |
| 044 | medical services in the nature of testing, analyzing in relation to the treatment and diagnosis of persons, and consulting services in the fields of genetic analysis, proteomic analysis, cellular analysis, multiomics, biomarkers, DNA sequencing, and bioinformatics, proteomics, genomics, secretomics, transcriptomics, and RNA sequencing; Medical testing services; medical information | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Cellanome, Inc.
- Other trademarks owned by Cellanome, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CELLCAGE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 15, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 14, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 14, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 14, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 14, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 19, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 19, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 13, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 15, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 14, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 14, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 14, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 14, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 13, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 12, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 12, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 12, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 12, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 12, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 7, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 22, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 31, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 31, 2024 | NWAP | NEW APPLICATION ENTERED | — |